Skip to content

Accuracy evaluation about blood glucose monitoring system

Accuracy evaluation about blood glucose monitoring system

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16008436
Enrollment
Unknown
Registered
2016-05-08
Start date
2016-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Gold Standard:
Index test:

Sponsors

The Teaching Hospital of Chengdu University of Triditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Volunteer who is over 18 years old with type 1 diabetes or type 2 diabetes orwithout or healthiness.

Exclusion criteria

Exclusion criteria: 1.The last six months had low blood pressure, faint at the sight of blood, venipuncture syncope, major cardiovascular event 2.Nearly two days used acetaminophen, salicylic acid, vitamin C, warfarin, heparin, low molecular heparin, and other anticoagulants. 3.Red blood cell volume: male > 55% or 40% or < 35%

Design outcomes

Primary

MeasureTime frame
blood glucose level;blood glucose level;

Countries

China

Contacts

Public ContactQiu Chen

The Affiliate Hospital of Chengdu University of Triditional Chinese Medicine

chenqiu1969@163.com+86 18981885702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026